Skip to main content

Correction: Expression of ADAM15 in rheumatoid synovium: up-regulation by vascular endothelial growth factor and possible implications for angiogenesis

The Original Article was published on 05 August 2005

Correction: Arthritis Res Ther 7, R1158 (2005)

https://doi.org/10.1186/ar1796

Following publication of the original article [1], an error was identified in Figs. 2 and 5. The correct figures are given below.

Fig. 2
figure 1

mRNA expression of ADAM species in rheumatoid arthritis (RA) and osteoarthritis (OA) synovial samples. Total RNA was extracted from RA or OA synovial tissue samples, and reverse transcribed into cDNA, followed by PCR as described in Materials and methods. Results from representative six RA (lanes 1-6) and six OA (lanes 7-12) synovial samples are shown. Although sample numbers of RA and OA cases were reduced from eight to six, the data in this corrected version of Fig. 2 are confirmatory to those in the original Fig. 2. C, positive controls. The cropped gel images in the corrected Fig. 2 are delineated, and the uncropped images for ADAM species and β–actin (full-length gels) are uploaded as ESM

Fig. 5
figure 2

Immunolocalization of ADAM15, VEGFR-2, vWF and CD31 in rheumatoid arthritis (RA) synovial tissues. Paraffin sections were stained with a hematoxylin and eosin or immunostained with antibodies against b ADAM15, c VEGFR-2, d vWF or e CD31, or f non-immune mouse IgG as described in Materials and methods. Note that ADAM15 is expressed in synovial lining cells and endothelial cells of blood vessels in the sublining layer (b). Immunostained sections were counterstained with hematoxylin. Arrows, synovial lining cells; arrowheads, endothelial cells of blood vessel. Scale bar, 100 μm

In addition, since the publication of the original article [1], it has come to our attention that we failed to include information for one of the authors in the competing interests section. The full competing interests section for this article can be found below.

Reference

  1. Komiya K, Enomoto H, Inoki I, et al. Expression of ADAM15 in rheumatoid synovium: up-regulation by vascular endothelial growth factor and possible implications for angiogenesis. Arthritis Res Ther. 2005;7:R1158. https://doi.org/10.1186/ar1796.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yasunori Okada.

Ethics declarations

Competing interests

Eiko Onuchi is affiliated with Daiichi Fine Chemical Co and developed the monoclonal antibody used in the experiment. The authors have no other competing interests to disclose.

Supplementary Information

Additional file 1.

Supplementary figures.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Komiya, K., Enomoto, H., Inoki, I. et al. Correction: Expression of ADAM15 in rheumatoid synovium: up-regulation by vascular endothelial growth factor and possible implications for angiogenesis. Arthritis Res Ther 24, 244 (2022). https://doi.org/10.1186/s13075-022-02936-1

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s13075-022-02936-1